A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures

Status:
Active, not recruiting

Trial end date:
2022-04-01

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the long-term safety, tolerability and efficacy of lacosamide (LCM) in pediatric subjects.

Phase 3

UCB BIOSCIENCES, Inc.

PRA Health Sciences
UCB Biopharma SRL

Lacosamide